O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-4.98%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.79B
AUM Growth
+$7.79B
(-11%)
Cap. Flow
-$283M
Cap. Flow
% of AUM
-3.63%
Top 10 Holdings %
Top 10 Hldgs %
37.29%
Holding
146
New
9
Increased
32
Reduced
26
Closed
16
Top Buys
| 1 |
Elevance Health
ELV
|
$147M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$91.8M |
| 3 |
AET
Aetna Inc
AET
|
$85.5M |
| 4 |
Humana
HUM
|
$84.2M |
| 5 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$74.7M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$146M |
| 2 |
Molina Healthcare
MOH
|
$116M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$102M |
| 4 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$89.8M |
| 5 |
AbbVie
ABBV
|
$81.7M |
Sector Composition
| 1 | Healthcare | 94.69% |
| 2 | Financials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.2B
| $106M | 1.34% | 1,274,100 +122,200 | +11% | +$10.1M |
|
|
AET
27
DELISTED
Aetna Inc
AET
| $99.9M | 1.27% | 805,900 +689,300 | +591% | +$85.5M |
|
28
Johnson & Johnson
JNJ
$427B
| $98.9M | 1.26% | 858,000 | – | – |
|
29
Intuitive Surgical
ISRG
$170B
| $92.3M | 1.18% | 145,500 -42,300 | -23% | -$26.8M |
|
|
BOLD
30
DELISTED
Audentes Therapeutics, Inc
BOLD
| $87.7M | 1.12% | 4,801,638 | – | – |
|
31
Bristol-Myers Squibb
BMY
$96B
| $87.3M | 1.11% | 1,493,500 -693,900 | -32% | -$40.6M |
|
32
Neurocrine Biosciences
NBIX
$13.8B
| $82.4M | 1.05% | 2,128,774 +313,300 | +17% | +$12.1M |
|
33
Corvus Pharmaceuticals
CRVS
$428M
| $76.9M | 0.98% | 5,379,349 | – | – |
|
34
Gilead Sciences
GILD
$140B
| $75.6M | 0.96% | 1,055,100 -955,600 | -48% | -$68.4M |
|
35
Glaukos
GKOS
$5.5B
| $74.8M | 0.95% | 2,180,000 | – | – |
|
|
MNK
36
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $73.4M | 0.93% | 1,472,700 +302,500 | +26% | +$15.1M |
|
37
Insmed
INSM
$28.8B
| $70.1M | 0.89% | 5,301,805 +50,705 | +1% | +$671K |
|
38
Puma Biotechnology
PBYI
$254M
| $69.9M | 0.89% | 2,275,825 -107,700 | -5% | -$3.31M |
|
|
AGN.PRA
39
DELISTED
Allergan plc.
AGN.PRA
| – | – | -88,200 | Closed | -$72.5M |
|
|
MGLN
40
DELISTED
Magellan Health Services, Inc.
MGLN
| $60.3M | 0.77% | 801,600 +101,900 | +15% | +$7.67M |
|
|
AERI
41
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $56.6M | 0.72% | 1,496,000 +698,900 | +88% | +$26.5M |
|
|
INSY
42
DELISTED
Insys Therapeutics, Inc.
INSY
| $55.9M | 0.71% | 6,071,440 +569,200 | +10% | +$5.24M |
|
|
LOXO
43
DELISTED
Loxo Oncology, Inc
LOXO
| $55.5M | 0.71% | 1,728,000 | – | – |
|
44
Tenet Healthcare
THC
$16.3B
| $55.2M | 0.7% | 3,716,700 +1,723,700 | +86% | +$25.6M |
|
45
Ascendis Pharma
ASND
$11.8B
| $55M | 0.7% | 2,717,315 +526,315 | +24% | +$10.7M |
|
46
Medtronic
MDT
$119B
| $54.6M | 0.7% | 766,600 | – | – |
|
|
ACHN
47
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $54.1M | 0.69% | 13,107,200 | – | – |
|
|
EGRX
48
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $53.2M | 0.68% | 671,000 -365,100 | -35% | -$29M |
|
49
UnitedHealth
UNH
$281B
| $47.4M | 0.6% | 296,400 -315,400 | -52% | -$50.5M |
|
|
MNTA
50
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $44.4M | 0.57% | +2,951,968 | New | +$44.4M |
|